Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Investigating CTCs in NSCLC-a reaction to the study of Jia-Wei Wan: a preliminary study on the relationship between circulating tumor cells count and clinical features in patients with non-small cell lung cancer.

Literature DB >> 27293811

Investigating CTCs in NSCLC-a reaction to the study of Jia-Wei Wan: a preliminary study on the relationship between circulating tumor cells count and clinical features in patients with non-small cell lung cancer.

Menno Tamminga¹, Hendricus Harry Johannes Marie Groen¹, Thijo Jeroen Nicolaas Hiltermann¹.

Abstract

Entities: Disease Species

Year: 2016 PMID： 27293811 PMCID： PMC4885991 DOI： 10.21037/jtd.2016.04.17

Source DB: PubMed Journal: J Thorac Dis ISSN： 2072-1439 Impact factor: 2.895

× No keyword cloud information.

25 in total

1. Fluid biopsy for circulating tumor cell identification in patients with early-and late-stage non-small cell lung cancer: a glimpse into lung cancer biology.

Authors: Marco Wendel; Lyudmila Bazhenova; Rogier Boshuizen; Anand Kolatkar; Meghana Honnatti; Edward H Cho; Dena Marrinucci; Ajay Sandhu; Anthony Perricone; Patricia Thistlethwaite; Kelly Bethel; Jorge Nieva; Michel van den Heuvel; Peter Kuhn
Journal: Phys Biol Date: 2012-02-03 Impact factor: 2.583

2. Detection of circulating tumor cells as a prognostic factor in patients undergoing radical surgery for non-small-cell lung carcinoma: comparison of the efficacy of the CellSearch Assay™ and the isolation by size of epithelial tumor cell method.

Authors: Véronique Hofman; Marius I Ilie; Elodie Long; Eric Selva; Christelle Bonnetaud; Thierry Molina; Nicolas Vénissac; Jérôme Mouroux; Philippe Vielh; Paul Hofman
Journal: Int J Cancer Date: 2011-03-11 Impact factor: 7.396

3. Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches.

Authors: Matthew G Krebs; Jian-Mei Hou; Robert Sloane; Lee Lancashire; Lynsey Priest; Daisuke Nonaka; Tim H Ward; Alison Backen; Glen Clack; Andrew Hughes; Malcolm Ranson; Fiona H Blackhall; Caroline Dive
Journal: J Thorac Oncol Date: 2012-02 Impact factor: 15.609

4. Reproducible copy number variation patterns among single circulating tumor cells of lung cancer patients.

Authors: Xiaohui Ni; Minglei Zhuo; Zhe Su; Jianchun Duan; Yan Gao; Zhijie Wang; Chenghang Zong; Hua Bai; Alec R Chapman; Jun Zhao; Liya Xu; Tongtong An; Qi Ma; Yuyan Wang; Meina Wu; Yu Sun; Shuhang Wang; Zhenxiang Li; Xiaodan Yang; Jun Yong; Xiao-Dong Su; Youyong Lu; Fan Bai; X Sunney Xie; Jie Wang
Journal: Proc Natl Acad Sci U S A Date: 2013-12-09 Impact factor: 11.205

5. Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay.

Authors: Nikki Parker; Mary Jo Turk; Elaine Westrick; Jeffrey D Lewis; Philip S Low; Christopher P Leamon
Journal: Anal Biochem Date: 2005-03-15 Impact factor: 3.365

6. Diagnostic leukapheresis enables reliable detection of circulating tumor cells of nonmetastatic cancer patients.

Authors: Johannes C Fischer; Dieter Niederacher; Stefan A Topp; Ellen Honisch; Sarah Schumacher; Norma Schmitz; Luisa Zacarias Föhrding; Christian Vay; Imke Hoffmann; Nikola S Kasprowicz; Philip G Hepp; Svjetlana Mohrmann; Ulrike Nitz; Antje Stresemann; Thomas Krahn; Tanja Henze; Evelyn Griebsch; Katharina Raba; Jutta M Rox; Folker Wenzel; Christoph Sproll; Wolfgang Janni; Tanja Fehm; Christoph A Klein; Wolfram Trudo Knoefel; Nikolas H Stoecklein
Journal: Proc Natl Acad Sci U S A Date: 2013-09-24 Impact factor: 11.205

7. Folate receptor alpha expression in lung cancer: diagnostic and prognostic significance.

Authors: Daniel J O'Shannessy; Gordon Yu; Robert Smale; Yao-Shi Fu; Sunil Singhal; Robert P Thiel; Elizabeth B Somers; Anil Vachani
Journal: Oncotarget Date: 2012-04

8. The detection of EpCAM(+) and EpCAM(-) circulating tumor cells.

Authors: Sanne de Wit; Guus van Dalum; Aufried T M Lenferink; Arjan G J Tibbe; T Jeroen N Hiltermann; Harry J M Groen; Cees J M van Rijn; Leon W M M Terstappen
Journal: Sci Rep Date: 2015-07-17 Impact factor: 4.379

9. Evaluation of Circulating Tumor Cells and Related Events as Prognostic Factors and Surrogate Biomarkers in Advanced NSCLC Patients Receiving First-Line Systemic Treatment.

Authors: Laura Muinelo-Romay; Maria Vieito; Alicia Abalo; Marta Alonso Nocelo; Francisco Barón; Urbano Anido; Elena Brozos; Francisca Vázquez; Santiago Aguín; Miguel Abal; Rafael López López
Journal: Cancers (Basel) Date: 2014-01-21 Impact factor: 6.639

Investigating CTCs in NSCLC-a reaction to the study of Jia-Wei Wan: a preliminary study on the relationship between circulating tumor cells count and clinical features in patients with non-small cell lung cancer.

1. Fluid biopsy for circulating tumor cell identification in patients with early-and late-stage non-small cell lung cancer: a glimpse into lung cancer biology.

2. Detection of circulating tumor cells as a prognostic factor in patients undergoing radical surgery for non-small-cell lung carcinoma: comparison of the efficacy of the CellSearch Assay™ and the isolation by size of epithelial tumor cell method.

3. Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches.

4. Reproducible copy number variation patterns among single circulating tumor cells of lung cancer patients.

5. Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay.

6. Diagnostic leukapheresis enables reliable detection of circulating tumor cells of nonmetastatic cancer patients.

7. Folate receptor alpha expression in lung cancer: diagnostic and prognostic significance.

8. The detection of EpCAM(+) and EpCAM(-) circulating tumor cells.

9. Evaluation of Circulating Tumor Cells and Related Events as Prognostic Factors and Surrogate Biomarkers in Advanced NSCLC Patients Receiving First-Line Systemic Treatment.

10. Quantification of rare circulating tumor cells in non-small cell lung cancer by ligand-targeted PCR.

1. ¹²⁵I inhibited the NSCLC both in vivo and in vitro.

2. MiR-130 exerts tumor suppressive function on the tumorigenesis of human non-small cell lung cancer by targeting PTEN.

Review 3. The applications of liquid biopsy in resistance surveillance of anaplastic lymphoma kinase inhibitor.

4. Circulating Tumor Cell Identification Based on Deep Learning.

5. The combination of CTCs and CEA can help guide the management of patients with SPNs suspected of being lung cancer.